Discover 2,242 paid clinical trials in San Jose, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Jose currently offers many active clinical trials with a particular emphasis on diabetes, Parkinson’s disease, Alzheimer’s disease, and cardiovascular conditions. Whether you’re looking for trials related to a specific health condition or interested in paid research as a healthy volunteer, San Jose’s diverse studies provide a variety of choices to explore new treatments while contributing to the future of medicine.
Filter
2
Filter results
Results: 2,242
Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Palo Alto CA, San Antonio TX, Toronto, Fairfax VA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06532565
Phase 1, Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Stanford CA, Sacramento CA, Los Angeles CA, Duarte CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05614739
Phase 1, Recruiting
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
for
Gastrointestinal Stromal Tumor (GIST),
Location: Palo Alto CA, Santa Monica CA, Los Angeles CA,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06655246
Phase 1, Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Palo Alto CA, Milwaukee WI, Chicago IL, Atlanta GA,
Sponsor: Ichnos Sciences SA
Sex: All
Age: 18+
Code: NCT05862012
Phase 1, Recruiting
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Palo Alto CA, San Francisco CA, Portland OR, Seattle WA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
for
Lupus Erythematosus, Systemic
Location: San Francisco CA, Seattle WA, St Louis MO, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70
Code: NCT06897930
Phase 1, Phase 2, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant, Mucosal Melanoma
Location: Stanford CA, San Francisco CA, Los Angeles CA,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase 3, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Location: San Francisco CA, San Antonio TX, Houston TX,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06952010
Phase 1, Recruiting
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
for
Prostate Adenocarcinoma, Prostate Cancer,
Location: San Francisco CA, St Louis MO
Sponsor: David Oh
Sex: Male
Age: 18+
Code: NCT03821246
Phase 2, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer